Research‎ > ‎

Dr. Micha Wilhelmus

Dr. Wilhelmus studied Alzheimer’s disease (AD), and especially cerebral amyloid angiopathy (CAA), pathology as an undergraduate student in 2001 at the department of Pathology of the Radboud University Nijmegen Medical Centre (RUNMC). Thereafter, from 2002 until 2006 he investigated both the role of Apolipoprotein E and small heat shock proteins in AD and CAA pathology as a PhD-student at the department of Neurology (RUNMC). In the period of 2006-2007, Dr. Wilhelmus worked as a postdoc at this department in a project on the role of amyloid-b-receptors in AD pathology. From 2008 onwards, Dr. Wilhelmus worked as a postdoctoral fellow and project leader in the Neuropharmacology group led by Dr. Drukarch, investigating the role of transglutaminases in AD at the department of Anatomy and Neurosciences, VU University Medical Center, Amsterdam. Currently, Dr. Wilhelmus continues this work focussing on the pathogenesis of neurodegenerative diseases and development of neuroprotective strategies as an assistant professor in the Neuropharmacology group.

Thesis of Micha Wilhelmus.
Comments